Cancer Immunotherapy Breakthroughs Spotlight Critical Role of Antibody Humanization—Creative Biolabs Sharpens Its Edge
Creative Biolabs stands as a powerhouse of antibody engineering expertise, whose end-to-end humanization platform is turning xenogeneic antibodies into preclinical frontrunners.
A Ludwig Cancer Research team has cracked a metabolic code tumors use to evade immune attack, unveiling a humanized antibody that reignites anti-cancer immunity in resistant liver cancers, which was published in Cancer Discovery. The CD36-blocking antibody PLT012 overcomes lipid-driven immunosuppression, which is a game-changer for tumors exploiting fatty microenvironments.